DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer.

Galle, Eva

DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer. [electronic resource] - Clinical epigenetics 02 2020 - 27 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1868-7083

10.1186/s13148-020-0821-z doi


Azacitidine--therapeutic use
Carcinoma, Hepatocellular--drug therapy
Cell Line, Tumor--drug effects
Circulating Tumor DNA--genetics
DNA Methylation--genetics
Drug Resistance, Neoplasm--genetics
Enzyme Inhibitors--therapeutic use
Epigenesis, Genetic
Epithelial-Mesenchymal Transition--genetics
Gene Expression Regulation, Neoplastic--genetics
Humans
Liver Neoplasms--pathology
MicroRNAs--genetics
Protein Kinase Inhibitors--therapeutic use
Sorafenib--therapeutic use